The reason to buy shares in Abbott Labs is simple:The company is growing its top line faster than just about any health-care company of comparable size and since it doesn’t sell pharmaceuticals in the U.S., it is relatively insulated from regulatory risk.
from WSJ.com: Markets https://ift.tt/2nTe8gN
via https://ifttt.com/ IFTTT
No comments:
Post a Comment